Carli, G.* et al. Parkinson's Disease-Related pattern in isolated REM sleep behaviour disorder as a prodromal progression marker: 8-Year Follow-Up changes assessed at three time points. Eur. J. Nucl. Med. Mol. Imaging, DOI: 10.1007/s00259-025-07260-9 (2025)
Adebahr, S.* et al. The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy. Eur. J. Nucl. Med. Mol. Imaging 51, 558-567 (2024)
Carli, G.* et al. Occipital hypometabolism is a risk factor for conversion to Parkinson’s disease in isolated REM sleep behaviour disorder. Eur. J. Nucl. Med. Mol. Imaging 50, 3290-3301 (2023)
Delker, A.* et al. Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging. Eur. J. Nucl. Med. Mol. Imaging 50, 1280-1290 (2023)
Noltes, M.E.* et al. Towards in vivo characterization of thyroid nodules suspicious for malignancy using multispectral optoacoustic tomography. Eur. J. Nucl. Med. Mol. Imaging 50, 2736-2750 (2023)
Solomonidou, N.* et al. PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml. Eur. J. Nucl. Med. Mol. Imaging 50, 2529-2536 (2023)
Spohn, S.K.B.* et al. Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy. Eur. J. Nucl. Med. Mol. Imaging 50, 2537-2547 (2023)
Barbone, G.E.* et al. X-ray multiscale 3D neuroimaging to quantify cellular aging and neurodegeneration postmortem in a model of Alzheimer’s disease. Eur. J. Nucl. Med. Mol. Imaging 49, 4338-4357 (2022)
Ma, R. et al. An encoder-decoder network for direct image reconstruction on sinograms of a long axial field of view PET. Eur. J. Nucl. Med. Mol. Imaging 49, 4464-4477 (2022)
Spohn, S.K.B.* et al. The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysis. Eur. J. Nucl. Med. Mol. Imaging 50, 218-227 (2022)
Fang, H.Y.* et al. Targeted Hsp70 fluorescence molecular endoscopy detects dysplasia in Barrett's esophagus. Eur. J. Nucl. Med. Mol. Imaging, DOI: 10.1007/s00259-021-05582-y (2021)
Paprottka, K.J.* et al. Fully automated analysis combining [18F]-FET-PET and multiparametric MRI including DSC perfusion and APTw imaging: a promising tool for objective evaluation of glioma progression. Eur. J. Nucl. Med. Mol. Imaging 48, 4445-4455 (2021)
Kessel, K.A. et al. Integration of PET-imaging into radiotherapy treatment planning for low-grade meningiomas improves outcome. Eur. J. Nucl. Med. Mol. Imaging 47, 1391-1399 (2020)
Peeken, J.C. et al. A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patients. Eur. J. Nucl. Med. Mol. Imaging 47, 2968-2977 (2020)
Schmidt-Hegemann, N.S.* et al. Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy—a multicenter retrospective study. Eur. J. Nucl. Med. Mol. Imaging 47, 1852-1863 (2020)
Vogel, M.M. et al. Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy. Eur. J. Nucl. Med. Mol. Imaging 47, 2328-2338 (2020)
Laitinen, I.* et al. Assessment of in vivo glucagon receptor engagement in rat liver. Eur. J. Nucl. Med. Mol. Imaging 46, S707-S708 (2019)
Bolch, W.E.* et al. The ICRP reference pediatric phantoms - design, construction, and applications to nuclear medicine dosimetry. Eur. J. Nucl. Med. Mol. Imaging 45, S79-S79 (2018)
Höllriegl, V. & Li, W.B. Application of new ICRP biokinetic models for pharmacokinetic modelling of Radium-223 used for treatment of prostate cancer. Eur. J. Nucl. Med. Mol. Imaging 45, S242-S242 (2018)
Karimi Ghodoosi, E. et al. Comparison of absorbed dose to kidneys using quantitative SPECT/CT and whole body planar images for Lu-177-PSMA I&T in prostate cancer therapy. Eur. J. Nucl. Med. Mol. Imaging 45, S112-S113 (2018)
Li, W.B. et al. Feasibility study of applying ICRP biokinetic models for pharmacokinetic modelling of alpha-emitter thorium-227 used in targeted radionuclide therapy. Eur. J. Nucl. Med. Mol. Imaging 45, S125-S125 (2018)
Ma, R.* ; Qiu, R.* ; Li, W.B. & Li, J.* Patient specific internal dose estimation based on quantitative SPECT\CT imaging. Eur. J. Nucl. Med. Mol. Imaging 45, S359-S359 (2018)
Schiller, K.* et al. Patterns of failure after radical prostatectomy in prostate cancer – implications for radiation therapy planning after 68Ga-PSMA-PET imaging. Eur. J. Nucl. Med. Mol. Imaging 44, 1656–1662 (2017)
Handkiewicz-Junak, D.* et al. Gene signature of the post-Chernobyl papillary thyroid cancer. Eur. J. Nucl. Med. Mol. Imaging 43, 1267-1277 (2016)
Kijanka, M.* et al. Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery. Eur. J. Nucl. Med. Mol. Imaging 40, 1718-1729 (2013)
Essler, M.* et al. Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis. Eur. J. Nucl. Med. Mol. Imaging 39, 602-612 (2012)
Graf, N.* et al. [18F]FLT is superior to [18F]FDG for predicting early response to antiproliferative treatment in high-grade lymphoma in a dose-dependent manner. Eur. J. Nucl. Med. Mol. Imaging 40, 34-43 (2012)
Vallon, M.* et al. Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrest. Eur. J. Nucl. Med. Mol. Imaging 39, 1886-1897 (2012)
Kiessling, F.* ; Razansky, D. & Alves, F.* Anatomical and microstructural imaging of angiogenesis. Eur. J. Nucl. Med. Mol. Imaging 37, (Suppl.1), S4-S19 (2010)
Seidl, C.* et al. Cell death triggered by alpha-emitting 213Bi-immunoconjugates in HSC45-M2 gastric cancer cells is different from apoptotic cell death. Eur. J. Nucl. Med. Mol. Imaging 32, 274-285 (2005)
Daldrup-Link, H.E.* et al. Cell tracking with gadophrin-2: A biofunctional contrast agent for MR imaging, optical imaging and fluorescence microscopy. Eur. J. Nucl. Med. Mol. Imaging 31, 1312-1321 (2004)
Smith, T.* ; Petoussi-Henß, N. & Zankl, M. Comparison of internal radiation doses estimated by MIRD and voxel techniques for a "family" of phantoms. Eur. J. Nucl. Med. Mol. Imaging 27, 1387-1398 (2000)
Ercan, M.T. ; Schneidereit, M. ; Senekowitsch, R. & Kriegel, H. Evaluation of 99mTc-dextran as a lymphoscintigraphic agent in rabbits. Eur. J. Nucl. Med. Mol. Imaging 11, 80-84 (1985)
Senekowitsch, R. ; Kriegel, H. ; Siegle, M. & Brachmann, F. Evaluation of ossification in jaw defects by radio-nuclide imaging. Eur. J. Nucl. Med. Mol. Imaging 7, 155-157 (1982)
Roth, P. ; Werner, E.E. & Kaltwasser, J.P. Ferrokinetics: Ineffective erythropoiesis and iron accumulation in bone marrow reticuloendothelial cells. Eur. J. Nucl. Med. Mol. Imaging 6, No.144 (1981)
Pabst, H.W.* ; Hör, G.* ; Lichte, H.* ; Sebening, H.* & Kriegel, H. Experience with 201Thallium in detection of myocardial infarction. Eur. J. Nucl. Med. Mol. Imaging 1, 19-25 (1976)